THINKING OUTSIDE THE BRAIN
Transforming the Understanding and Treatment of Neurodegeneration
![](https://immunobrain.com/wp-content/uploads/2023/11/h1a.jpg)
![](https://immunobrain.com/wp-content/uploads/2023/11/h2.jpg)
Redefining the treatment of neurological disorders
At ImmunoBrain Checkpoint, we pioneer a transformative approach for treating neurological disorders, one that leverages the body’s own defense mechanisms: harnessing the power of the peripheral immune system in mitigating brain pathology.
Alzheimer’s disease clinical trial
We are currently investigating our lead program IBC-Ab002, a novel anti-PD-L1 antibody, in patients with early Alzheimer’s disease.
![](https://immunobrain.com/wp-content/uploads/2023/11/h3.jpg)
![](https://immunobrain.com/wp-content/uploads/2023/11/h4.jpg)
Targeting the peripheral immune system to benefit the brain
ImmunoBrain is building upon its unique understanding of how the peripheral immune system communicates with the brain.
![](https://immunobrain.com/wp-content/uploads/2023/12/PicturesTo_immuno051223_11.jpg)